Arvinas (ARVN) Operating Leases (2019 - 2026)
Arvinas (ARVN) recorded quarterly Operating Leases of $6.3 million in Q1 2026, down 7.35% quarter-over-quarter from $6.8 million in Q4 2025, and down 37.0% on a YoY basis from $10.0 million in Q1 2025.
Arvinas (ARVN) Operating Leases (2019 - 2026) Analysis & Trends
Arvinas' Operating Leases history runs 8 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- In Q1 2026, Operating Leases fell 37.0% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 37.0% YoY), while the FY2025 annual figure was $6.8 million, down 6.85% from the prior year.
- Operating Leases was $6.3 million for Q1 2026 at Arvinas, down from $6.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $10.0 million in Q1 2025 to a low of $100000.0 in Q3 2024.
- Historically, Operating Leases has averaged $4.4 million across 5 years, with a median of $4.1 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 96.67% in 2024, then jumped 8800.0% in 2025.
- A 5-year view of Operating Leases shows it stood at $2.7 million in 2022, then plunged by 81.48% to $500000.0 in 2023, then jumped by 1360.0% to $7.3 million in 2024, then retreated by 6.85% to $6.8 million in 2025, then fell by 7.35% to $6.3 million in 2026.
- The last three Operating Leases figures came in at $6.3 million (Q1 2026), $6.8 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.30 Mn |
| Dec 31, 2025 | 6.80 Mn |
| Sep 30, 2025 | 8.90 Mn |
| Jun 30, 2025 | 7.60 Mn |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 3.19 Mn |
| Jun 30, 2021 | 3.40 Mn |